SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Moleculin Biotech Q3 net loss narrows as MIRACLE trial advances

Moleculin Biotech Q3 net loss narrows as MIRACLE trial advances Overview US biotech firm posted Q3 n

MBRX

Related stories